DAVID JAMES DILLON M.D. NPI 1033503172

NPI Information

  • NPI: 1033503172
  • Provider Name: DAVID JAMES DILLON, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1050 NW 15TH ST STE 212A
    BOCA RATON, FL
    ZIP 33486
  • Phone: (561) 368-5611

Map and Directions

Get Directions

NPI Details

David James Dillon, M.D. is a rheumatology internal medicine in Boca Raton, FL with 11 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. David James Dillon, M.D. NPI is 1033503172. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1050 NW 15TH ST STE 212A
BOCA RATON, FL
ZIP 33486-390
Phone: (561) 368-5611

The NPI 1033503172 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Blood creatinine level (HCPCS:82565)
  • Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
  • Liver function blood test panel (HCPCS:80076)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Vitamin d-3 level (HCPCS:82306)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Calcium level, total (HCPCS:82310)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
  • Phosphate level (HCPCS:84100)
  • Phosphatase (enzyme) measurement, alkaline, isoenzymes (HCPCS:84080)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
  • Rheumatoid factor analysis (HCPCS:86430)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Parathormone (parathyroid hormone) level (HCPCS:83970)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Uric acid level, blood (HCPCS:84550)
  • Blood glucose (sugar) level (HCPCS:82947)
  • Blood potassium level (HCPCS:84132)
  • Blood sodium level (HCPCS:84295)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • Screening test for antibody to noninfectious agent (HCPCS:86255)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, hydrocortisone sodium succinate, up to 100 mg (HCPCS:J1720)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Measurement of dna antibody, native or double stranded (HCPCS:86225)
  • Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
  • Iron level (HCPCS:83540)

The enumeration date for this NPI number is 3/26/2015 and was last updated on 9/20/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatologyME145444FLORIDAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.